Histopathology of Non-Alcoholic Fatty Liver Disease

被引:105
作者
Brunt, Elizabeth M. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
NASH; Steatosis; Histologic lesions; INTRAHEPATIC TRIGLYCERIDE CONTENT; MORBIDLY OBESE-PATIENTS; HEPATIC STEATOSIS; SAMPLING VARIABILITY; INSULIN-RESISTANCE; HEPATOCYTE APOPTOSIS; HISTOLOGIC SPECTRUM; AFRICAN-AMERICAN; ADIPOSE-TISSUE; STEATOHEPATITIS;
D O I
10.1016/j.cld.2009.07.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Current imaging methodologies can detect steatosis with increasing accuracy but cannot detect inflammation or pre-cirrhotic fibrosis or remodeling of the liver parenchyma. Imaging also cannot assess types or localization of hepatic steatosis. With the increased use of rodents to study NAFLD/NASH, careful analysis or reading highlights the fact that liver tissue evaluations reported in many of the popular animal models of NAFLD/NASH often do not imitate many of the significant aspects of the human disease, despite similar terminology applied by investigators. This review will focus on the findings in human disease.
引用
收藏
页码:533 / +
页数:13
相关论文
共 50 条
  • [41] Role of Leptin in Non-Alcoholic Fatty Liver Disease
    Jimenez-Cortegana, Carlos
    Garcia-Galey, Alba
    Tami, Malika
    del Pino, Pilar
    Carmona, Isabel
    Lopez, Soledad
    Alba, Gonzalo
    Sanchez-Margalet, Victor
    BIOMEDICINES, 2021, 9 (07)
  • [42] Non-alcoholic fatty liver disease: A sign of systemic disease
    Reccia, Isabella
    Kumar, Jayant
    Akladios, Cherif
    Virdis, Francesco
    Pai, Madhava
    Habib, Nagy
    Spalding, Duncan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 72 : 94 - 108
  • [43] Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
    Teng, Tieshan
    Qiu, Shuai
    Zhao, Yiming
    Zhao, Siyuan
    Sun, Dequan
    Hou, Lingzhu
    Li, Yihang
    Zhou, Ke
    Yu, Xixi
    Yang, Changyong
    Li, Yanzhang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [44] The effect of endurance training on non-alcoholic fatty liver disease in mice
    Melo, Luma
    Bilici, Merve
    Hagar, Amit
    Klaunig, James E.
    PHYSIOLOGICAL REPORTS, 2021, 9 (15):
  • [45] Altered clot kinetics in patients with non-alcoholic fatty liver disease
    Hickman, Ingrid J.
    Sullivan, Clair M.
    Flight, Simone
    Campbell, Catherine
    Crawford, Darrell H.
    Masci, Paul. P.
    O'Moore-Sullivan, Trisha M.
    Prins, Johannes B.
    Macdonald, Graeme A.
    ANNALS OF HEPATOLOGY, 2009, 8 (04) : 331 - 338
  • [46] The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
    Xu, Hao
    Wang, Lin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [47] Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
    Mohanty, Smruti R.
    Troy, Tara N.
    Hu, Dezheng
    O'Brien, Bridget L.
    Jensen, Donald M.
    Hart, Johri
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 797 - 804
  • [48] Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
    Schwenger, Katherine J. P.
    Bolzon, Colin M.
    Li, Carrie
    Allard, Johane P.
    EUROPEAN JOURNAL OF NUTRITION, 2019, 58 (05) : 1771 - 1784
  • [49] Gut microbiota and non-alcoholic fatty liver disease: new insights
    Aron-Wisnewsky, J.
    Gaborit, B.
    Dutour, A.
    Clement, K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 338 - 348
  • [50] Non-alcoholic fatty liver disease and liver secretome
    Khan, Muhammad Sohaib
    Lee, Choongho
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963